Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy? - Wikidata - awgldk - TriplyDB

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

http://www.wikidata.org/entity/Q35208114

about

Elucidation of the molecular mechanisms of two nanobodies that inhibit thrombin-activatable fibrinolysis inhibitor activation and activated thrombin-activatable fibrinolysis inhibitor activity Concise total synthesis of (±)-actinophyllic acid.TAFIa inhibiting nanobodies as profibrinolytic tools and discovery of a new TAFIa conformation.Substrate specificity of human carboxypeptidase A6.Ambivalent roles of carboxypeptidase B in the lytic susceptibility of fibrin.Insights into thrombin activatable fibrinolysis inhibitor function and regulation.Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.Measuring fibrinolysis: from research to routine diagnostic assays.Structure of the carboxypeptidase B complex with N-sulfamoyl-L-phenylalanine - a transition state analog of non-specific substrate.

P2860

Q27709157-8E54AF55-25D6-403F-ABB3-0E7BB7786458 Q33665029-3709FC2C-4240-4764-823E-BCEBDE579685 Q34007678-F213F60C-4353-4939-BB3B-D44BD48C1FE5 Q34139062-592E4CBE-9E8F-441D-8902-989E5DA2D931 Q35008316-DD42FADE-7F63-48B5-ACE0-FD4AB495BD5F Q38117742-FE2E3026-31B1-485D-8279-3307273E6133 Q42588928-1265A106-88A9-426A-BA1E-F8A467144F9B Q47715508-32B71114-1D38-4CD0-8EA7-A56036E134D9 Q51105799-42D719B1-FEB2-4351-A992-B2179F026F73

P2860

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

http://www.wikidata.org/entity/Q35208114

description

2009 nî lūn-bûn

@nan

2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

@ast

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

@en

type

label

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

@ast

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

@en

prefLabel

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

@ast

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

@en

P1433

Q35208114-09F42F0B-63E2-4B5E-AF52-7E311649AAF1

P1476

Q35208114-D667C7C1-B482-45A6-A256-60E314D990CD

P2093

Q35208114-410DD597-B97F-4376-94F6-C9751DE51391

Q35208114-818664E3-40C9-40DA-B8FF-A7BBFE199D69

Q35208114-AE50E1A7-5F49-418A-896D-16CE191E351A

Q35208114-D2C85537-8C21-4704-A208-46298D8E1F60

P2860

Q35208114-0226AB4F-8007-45AC-A9AA-C907392086B8

Q35208114-03E3C0BD-4C25-45AD-9F2E-8FF792BF9CEA

Q35208114-0479CB12-48A2-4C88-9502-8AA7A9DF9066

Q35208114-05E423EA-3D62-4531-BA40-1C0842070D13

Q35208114-06005F66-140A-42D7-9AF8-2F0D2B6A3C64

Q35208114-09553438-B0BD-4C6B-AB37-3E75FBCDC350

Q35208114-110B1F24-A52E-4ACC-973A-AA51B1D15D98

Q35208114-1C875839-75FE-4F0C-BB77-096AEC006951

Q35208114-1C9986E8-19F8-45D8-98D8-23717E9CCCC5

Q35208114-1E4F5E02-665F-481F-AF1A-F4152F454BCB

P304

Q35208114-64D3C9B5-7835-4210-B796-72D04657717D

P31

Q35208114-C124F0EB-EEE7-4980-ACF7-B05DE4D76539

P356

Q35208114-01AD2AE9-9493-4327-A205-75D6A988BE71

P433

Q35208114-9B7CD085-F2BC-4E3A-8D69-4120CC22DA89

P478

Q35208114-A4F68466-A345-478D-BC2F-E17DCE010DEC

P577

Q35208114-6B4E0530-1DB9-4325-82B4-0C83D61BBB55

P5875

Q35208114-295188BB-AE6F-448F-87A5-D87974FDFDD4

P698

Q35208114-4F483B8B-7CD2-4FC0-A26B-2C03E9BAF2D3

P932

Q35208114-4097ABE8-0D9A-4BFC-A56A-7E025EE6A681

P356

J.1538-7836.2009.03596.X

P1433

Journal of Thrombosis and Haemostasis

P1476

Carboxypeptidase U (TAFIa): a new drug target for fibrinolytic therapy?

@en

P2093

D F Hendriks

http://www.w3.org/2001/XMLSchema#string

E Heylen

http://www.w3.org/2001/XMLSchema#string

J L Willemse

http://www.w3.org/2001/XMLSchema#string

M E Nesheim

http://www.w3.org/2001/XMLSchema#string

P2860

Plasma carboxypeptidases as regulators of the plasminogen system

Discovery of potent & selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosis

Structures of potent selective peptide mimetics bound to carboxypeptidase B

Crystal structures of TAFI elucidate the inactivation mechanism of activated TAFI: a novel mechanism for enzyme autoregulation

Structure of activated thrombin-activatable fibrinolysis inhibitor, a molecular link between coagulation and fibrinolysis

Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma

Pro-carboxypeptidase R cleaves bradykinin following activation

Carboxypeptidase U, a plasma carboxypeptidase with high affinity for plasminogen

Activation and characterization of procarboxypeptidase B from human plasma

Pro-carboxypeptidase R is an acute phase protein in the mouse, whereas carboxypeptidase N is not

P304

1962-1971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1538-7836.2009.03596.X

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2009-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26779547

http://www.w3.org/2001/XMLSchema#string

P698

19719827

http://www.w3.org/2001/XMLSchema#string

P932

3170991

http://www.w3.org/2001/XMLSchema#string